Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges

• Egile Nagusiak: Mateusz Hasso-Agopsowicz (Egilea), Natasha Crowcroft (Egilea), Robin Biellik (Egilea), Christopher J. Gregory (Egilea), Marion Menozzi-Arnaud (Egilea), Jean-Pierre Amorij (Egilea), Philippe-Alexandre Gilbert (Egilea), Kristen Earle (Egilea), Collrane Frivold (Egilea), Courtney Jarrahian (Egilea), Mercy Mvundura (Egilea), Jessica J. Mistilis (Egilea), David N. Durrheim (Egilea), Birgitte Giersing (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Measles and rubella microarray patches (MR-MAPs) are critical in achieving measles and rubella eradication, a goal highly unlikely to meet with current vaccines presentations. With low commercial incentive to MAP developers, limited and uncertain funding, the need for investment in a novel manufactu...